Alternative treatment to surgery for rectal cancer

Carregando...
Imagem de Miniatura
Citações na Scopus
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
AME PUBL CO
Autores
FERNANDEZ, Laura Melina
JULIAO, Guilherme Pagin Sao
VAILATI, Bruna Borba
Citação
ANNALS OF LAPAROSCOPIC AND ENDOSCOPIC SURGERY, v.3, article ID UNSP 50, 9p, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The traditional concept of rectal cancer management has changed significantly over the last few years. Although surgical resection remains central the treatment of distal rectal cancer by proctectomy and total mesorectal excision (TME), there has been increased interest in organ preservation strategies. Neoadjuvant chemoradiation (nCRT) may result in significant tumor regression and complete pathological response may be observed in up to 42% of patients. In order to avoid the morbidity, mortality and functional consequences of major surgery, selected patients with clinical and radiological evidence of significant tumor regression after nCRT have been managed non-operatively with strict follow-up (Watch & Wait Strategy-WW) with acceptable outcomes and minimal functional consequences. In addition, close surveillance may allow early detection of local recurrences and salvage alternatives with no oncological compromise.
Palavras-chave
Rectal cancer, organ-preservation, Watch & Wait
Referências
  1. Appelt AL, 2015, LANCET ONCOL, V16, P919, DOI 10.1016/S1470-2045(15)00120-5
  2. Appelt AL, 2013, INT J RADIAT ONCOL, V85, P74, DOI 10.1016/j.ijrobp.2012.05.017
  3. Bettoni F, 2017, ANN SURG, V265, pE4, DOI 10.1097/SLA.0000000000001937
  4. Borg C, 2014, ANN ONCOL, V25, P2205, DOI 10.1093/annonc/mdu377
  5. Bujko K, 2013, RADIOTHER ONCOL, V106, P198, DOI 10.1016/j.radonc.2012.12.005
  6. Carpinetti P, 2015, ONCOTARGET, V6, P38360, DOI 10.18632/oncotarget.5256
  7. Curvo-Semedo L, 2011, RADIOLOGY, V260, P734, DOI 10.1148/radiol.11102467
  8. Dattani M, 2018, ANN SURG
  9. Dellas K, 2014, ANN SURG ONCOL, V21, P1352, DOI 10.1245/s10434-013-3412-9
  10. dos Anjos DA, 2016, DIS COLON RECTUM, V59, P805, DOI 10.1097/DCR.0000000000000655
  11. Dossa F, 2017, LANCET GASTROENTEROL, V2, P501, DOI 10.1016/S2468-1253(17)30074-2
  12. Duldulao MP, 2013, DIS COLON RECTUM, V56, P142, DOI 10.1097/DCR.0b013e31827541e2
  13. Fornaro L, 2014, WORLD J GASTROENTERO, V20, P6081, DOI 10.3748/wjg.v20.i20.6081
  14. Francois Y, 1999, J CLIN ONCOL, V17, P2396, DOI 10.1200/JCO.1999.17.8.2396
  15. Garcia-Aguilar J, 2015, LANCET ONCOL, V16, P957, DOI 10.1016/S1470-2045(15)00004-2
  16. Garcia-Aguilar J, 2012, ANN SURG ONCOL, V19, P384, DOI 10.1245/s10434-011-1933-7
  17. Garcia-Aguilar J, 2011, ANN SURG, V254, P97, DOI 10.1097/SLA.0b013e3182196e1f
  18. Gerard J P, 2014, Recent Results Cancer Res, V203, P153, DOI 10.1007/978-3-319-08060-4_11
  19. Habr-Gama A, 2004, ANN SURG, V240, P711, DOI 10.1097/01.sla.0000141194.27992.32
  20. Habr-Gama A, 2017, DIS COLON RECTUM, V60, P586, DOI 10.1097/DCR.0000000000000830
  21. Habr-Gama A, 2016, DIS COLON RECTUM, V59, P264, DOI 10.1097/DCR.0000000000000543
  22. Habr-Gama A, 2015, HEMATOL ONCOL CLIN N, V29, P135, DOI 10.1016/j.hoc.2014.09.004
  23. Habr-Gama A, 2014, INT J RADIAT ONCOL, V88, P822, DOI 10.1016/j.ijrobp.2013.12.012
  24. Habr-Gama A, 2013, DIS COLON RECTUM, V56, P1109, DOI 10.1097/DCR.0b013e3182a25c4e
  25. Habr-Gama A, 2013, DIS COLON RECTUM, V56, P264, DOI 10.1097/DCR.0b013e318277e8e4
  26. Habr-Gama A, 2010, DIS COLON RECTUM, V53, P1692, DOI 10.1007/DCR.0b013e3181f42b89
  27. Habr-Gama A, 2009, DIS COLON RECTUM, V52, P1927, DOI 10.1007/DCR.0b013e3181ba14ed
  28. Hompes R, 2013, COLORECTAL DIS, V15, pe576, DOI 10.1111/codi.12381
  29. Hupkens BJP, 2017, DIS COLON RECTUM, V60, P1032, DOI 10.1097/DCR.0000000000000862
  30. Kalady MF, 2009, ANN SURG, V250, P582, DOI 10.1097/SLA.0b013e3181b91e63
  31. Kong JC, 2017, DIS COLON RECTUM, V60, P335, DOI 10.1097/DCR.0000000000000754
  32. Lambregts DMJ, EUR RADIOL
  33. Lambregts DMJ, 2011, DIS COLON RECTUM, V54, P1521, DOI 10.1097/DCR.0b013e318232da89
  34. Loos M, 2013, ANN SURG ONCOL, V20, P1816, DOI 10.1245/s10434-012-2827-z
  35. Lopes-Ramos C, 2015, CANCER GENET-NY, V208, P319, DOI 10.1016/j.cancergen.2015.03.010
  36. Maas M, 2015, ANN SURG ONCOL, V22, P3873, DOI 10.1245/s10434-015-4687-9
  37. Maas M, 2010, LANCET ONCOL, V11, P835, DOI 10.1016/S1470-2045(10)70172-8
  38. Morino M, 2013, SURG ENDOSC, V27, P3315, DOI 10.1007/s00464-013-2911-x
  39. Patel UB, 2011, J CLIN ONCOL, V29, P3753, DOI 10.1200/JCO.2011.34.9068
  40. Patel UB, 2012, ANN SURG ONCOL, V19, P2842, DOI 10.1245/s10434-012-2309-3
  41. Peeters KCMJ, 2005, J CLIN ONCOL, V23, P6199, DOI 10.1200/JCO.2005.14.779
  42. Perez RO, 2014, TECH COLOPROCTOL, V18, P699, DOI 10.1007/s10151-013-1113-9
  43. Perez RO, 2012, COLORECTAL DIS, V14, P714, DOI 10.1111/j.1463-1318.2011.02761.x
  44. Perez RO, 2016, DIS COLON RECTUM, V59, P895, DOI 10.1097/DCR.0000000000000620
  45. Perez RO, 2012, INT J RADIAT ONCOL, V84, P1159, DOI 10.1016/j.ijrobp.2012.01.096
  46. Perez RO, 2011, DIS COLON RECTUM, V54, P545, DOI 10.1007/DCR.0b013e3182083b84
  47. Radu C, 2008, RADIOTHER ONCOL, V87, P343, DOI 10.1016/j.radonc.2007.11.025
  48. Rullier E, 2017, LANCET, V390, P469, DOI 10.1016/S0140-6736(17)31056-5
  49. Sao Juliao GP, 2017, COLORECTAL DIS, V19, pO196, DOI 10.1111/codi.13691
  50. Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694
  51. Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836
  52. Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904
  53. Smith FM, 2010, BRIT J SURG, V97, P1752, DOI 10.1002/bjs.7251
  54. Smith FM, 2017, DIS COLON RECTUM, V60, P228, DOI 10.1097/DCR.0000000000000749
  55. Taylor FGM, 2011, ANN SURG, V253, P711, DOI 10.1097/SLA.0b013e31820b8d52
  56. Vailati BB, 2018, DIS COLON RECTUM, V61, pE21, DOI 10.1097/DCR.0000000000001018
  57. Vuong T, 2015, J CONTEMP BRACHYTHER, V7, P183, DOI 10.5114/jcb.2015.51402